The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in

Shahrzad Ossareh1, Neda Nazemzadeh, Mojgan Asgari

  • 1Department of Medicine, Nephrology section), Iran University of Medical Sciences (IUMS), Hasheminejad Kidney Center (HKC), Tehran, Iran. ossareh_s@hotmail.com.

Insights

The presence of crescents (C) and tubular atrophy/interstitial fibrosis (T) independently predict end-stage kidney disease (ESKD) in IgA nephropathy (IgAN) patients. High risk of ESKD is associated with combined T1 and C1 scores.

Area of Science:

  • Nephrology
  • Pathology
  • Immunology

Background:

  • IgA nephropathy (IgAN) is a common glomerular disease.
  • The Oxford classification (MEST score) aids prognostication.
  • Crescents (C) are a recent addition to the Oxford classification.

Purpose of the Study:

  • To evaluate the impact of crescents (C) on end-stage kidney disease (ESKD) development in IgAN patients.
  • To assess the added prognostic value of crescents to the MEST score.

Main Methods:

  • 115 IgAN patients were followed for a mean of 43 months.
  • MEST score components were assessed: mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental sclerosis (S), and tubular atrophy/interstitial fibrosis (T).
  • Crescents (C) were defined as C0 (absent) or C1 (present); T was defined as T0 (≤25%) or T1 (>25%).

Main Results:

  • 40 patients (35%) developed ESKD.
  • Crescents ≥ 30% (C1) and T1 were independently associated with increased ESKD risk (HR=3.15 and HR=7.18 respectively).
  • The combined presence of T1 and C1 significantly increased ESKD risk (74% developed ESKD).

Conclusions:

  • Tubular atrophy/interstitial fibrosis (T ≥ 25%) and crescents (≥ 30%) are independent predictors of ESKD in IgAN.
  • The combination of T1 and C1 signifies a high risk for ESKD.
  • These findings refine prognostication in IgAN patients.
Abstract

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
100
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
67
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
119
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
92
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
119
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
111